Phase 1 Study to Evaluate the Safety and Pharmacokinetics of Palbociclib (Ibrance) in Combination with Irinotecan and Temozolomide in Pediatric Patients with Recurrent or Refractory Solid Tumors


Total Award Amount

  • 157302.00
  • Direct Costs

  • 121001.00
  • Sponsor Award Id

  • Contributor

  • Elizabeth Alva   Investigator  
  • Emily Johnston   Investigator  
  • Girish Dhall   Investigator  
  • Gregory Friedman M.D.   Principal Investigator  
  • Jamie Aye   Investigator  
  • Kimberly Whelan M.D.   Investigator  
  • Laura Metrock   Investigator